name,category,terms3-oxoacid CoA transferase 2,COG_ONTOLOGY[90000084$Lipid metabolism]
3-oxoacid CoA transferase 2,INTERPRO[450003673$IPR004163:Coenzyme A transferase binding site, 450003674$IPR004164:Coenzyme A transferase active site, 450003675$IPR004165:Coenzyme A transferase, 450011470$IPR012791:3-oxoacid CoA-transferase, subunit B, 450011471$IPR012792:3-oxoacid CoA-transferase, subunit A, 450012966$IPR014388:3-oxoacid CoA-transferase]
3-oxoacid CoA transferase 2,KEGG_PATHWAY[470038735$hsa00072:Synthesis and degradation of ketone bodies, 470038748$hsa00280:Valine, leucine and isoleucine degradation, 470038790$hsa00650:Butanoate metabolism]
3-oxoacid CoA transferase 2,PIR_SUPERFAMILY[630000994$PIRSF000858:3-oxoacid CoA-transferase, 630000995$PIRSF000858:SCOT-t, 630010698$PIRSF012663:CoA-transferase, beta subunit]
3-oxoacid CoA transferase 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000969$mitochondrion, 790001212$polymorphism, 790001547$transferase, 790001550$transit peptide]
3-oxoacid CoA transferase 2,UP_SEQ_FEATURE[850062757$chain:Succinyl-CoA:3-ketoacid-coenzyme A transferase 2, mitochondrial, 850111264$region of interest:CoA-binding, 850117294$sequence conflict, 850117295$sequence variant, 850118617$transit peptide:Mitochondrion]
A kinase (PRKA) anchor protein 10,INTERPRO[450000294$IPR000342:Regulator of G protein signalling]
A kinase (PRKA) anchor protein 10,OMIM_DISEASE[520000755$Cardiac conduction defect, susceptibility to, 520002951$Longevity, reduced]
A kinase (PRKA) anchor protein 10,SMART[760000285$SM00315:RGS]
A kinase (PRKA) anchor protein 10,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790000919$membrane, 790000969$mitochondrion, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001550$transit peptide]
A kinase (PRKA) anchor protein 10,UP_SEQ_FEATURE[850002953$chain:A kinase anchor protein 10, mitochondrial, 850105179$domain:RGS 1, 850105180$domain:RGS 2, 850106258$modified residue, 850114056$region of interest:PKA-RII subunit binding, 850117294$sequence conflict, 850117295$sequence variant, 850118617$transit peptide:Mitochondrion]
ABI family, member 3,INTERPRO[450001294$IPR001452:Src homology-3 domain, 450011527$IPR012849:Abl-interactor, homeo-domain homologous region]
ABI family, member 3,SMART[760000295$SM00326:SH3]
ABI family, member 3,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001212$polymorphism, 790001398$sh3 domain]
ABI family, member 3,UP_SEQ_FEATURE[850003171$chain:ABI gene family member 3, 850102586$compositionally biased region:Pro-rich, 850105350$domain:SH3, 850117295$sequence variant]
CDC42 small effector 2,INTERPRO[450000079$IPR000095:PAK-box/P21-Rho-binding]
CDC42 small effector 2,SMART[760000256$SM00285:PBD]
CDC42 small effector 2,SP_PIR_KEYWORDS[790000264$cell membrane, 790000268$cell shape, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000881$lipoprotein, 790000919$membrane, 790001100$palmitate, 790001136$phagocytosis]
CDC42 small effector 2,UP_SEQ_FEATURE[850010191$chain:CDC42 small effector protein 2, 850102566$compositionally biased region:Poly-Arg, 850103411$domain:CRIB, 850105898$lipid moiety-binding region:S-palmitoyl cysteine]
E1A binding protein p300,BIOCARTA[30000046$h_carm-erPathway:CARM1 and Regulation of the Estrogen Receptor, 30000047$h_carm1Pathway:Transcription Regulation by Methyltransferase of CARM1, 30000121$h_g2Pathway:Cell Cycle: G2/M Checkpoint, 30000136$h_her2Pathway:Role of ERBB2 in Signal Transduction and Oncology, 30000138$h_hifPathway:Hypoxia-Inducible Factor in the Cardiovascular System, 30000161$h_il7Pathway:IL-7 Signal Transduction, 30000183$h_mef2dPathway:Role of MEF2D in T-cell Apoptosis, 30000184$h_melanocytepathway:Melanocyte Development and Pigmentation Pathway, 30000210$h_nthiPathway:NFkB activation by Nontypeable Hemophilus influenzae, 30000216$h_p53hypoxiaPathway:Hypoxia and p53 in the Cardiovascular system, 30000224$h_pelp1Pathway:Pelp1 Modulation of Estrogen Receptor Activity, 30000227$h_pitx2Pathway:Multi-step Regulation of Transcription by Pitx2, 30000235$h_pparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha), 30000236$h_ppargPathway:Role of PPAR-gamma Coactivators in Obesity and Thermogenesis, 30000259$h_RELAPathway:Acetylation and Deacetylation of RelA in The Nucleus, 30000293$h_tgfbPathway:TGF beta signaling pathway, 30000306$h_vdrPathway:Control of Gene Expression by Vitamin D Receptor]
E1A binding protein p300,INTERPRO[450000168$IPR000197:Zinc finger, TAZ-type, 450000371$IPR000433:Zinc finger, ZZ-type, 450001324$IPR001487:Bromodomain, 450002725$IPR003101:Coactivator CBP, KIX, 450008365$IPR009255:Transcriptional coactivation, 450009371$IPR010303:Protein of unknown function DUF902, CREBbp, 450013195$IPR014744:Nuclear receptor coactivator, CREB-bp-like, interlocking, 450016644$IPR018359:Bromodomain, conserved site]
E1A binding protein p300,KEGG_PATHWAY[470038834$hsa04110:Cell cycle, 470038846$hsa04310:Wnt signaling pathway, 470038848$hsa04330:Notch signaling pathway, 470038850$hsa04350:TGF-beta signaling pathway, 470038856$hsa04520:Adherens junction, 470038866$hsa04630:Jak-STAT signaling pathway, 470038876$hsa04720:Long-term potentiation, 470038885$hsa04916:Melanogenesis, 470038894$hsa05016:Huntington's disease, 470038899$hsa05200:Pathways in cancer, 470038901$hsa05211:Renal cell carcinoma, 470038905$hsa05215:Prostate cancer]
E1A binding protein p300,OMIM_DISEASE[520001093$Colorectal cancer, 520004363$Rubinstein-Taybi syndrome]
E1A binding protein p300,PIR_SUPERFAMILY[630027768$PIRSF036333:transcription coactivator CREB-binding protein]
E1A binding protein p300,SMART[760000262$SM00291:ZnF_ZZ, 760000267$SM00297:BROMO, 760000491$SM00551:ZnF_TAZ]
E1A binding protein p300,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000206$bromodomain, 790000258$cell cycle, 790000316$chromosomal rearrangement, 790000326$citrullination, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000733$host-virus interaction, 790000937$metal-binding, 790000953$methylation, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation, 790001547$transferase, 790001592$ubl conjugation, 790001648$zinc, 790001649$zinc finger, 790001651$zinc-finger]
E1A binding protein p300,UP_SEQ_FEATURE[850023871$chain:Histone acetyltransferase p300, 850102570$compositionally biased region:Poly-Gln, 850102572$compositionally biased region:Poly-Glu, 850102581$compositionally biased region:Poly-Ser, 850103166$domain:Bromo, 850104544$domain:KIX, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850111035$region of interest:Binding region for E1A adenovirus, 850112430$region of interest:Interaction with HTLV-1 Tax, 850112592$region of interest:Interaction with NCOA2, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850117911$site:Breakpoint for translocation to form MYST3-EP300 and EP300-MYST3, 850118319$site:Interaction with NCOA2, 850118575$strand, 850118624$turn, 850118931$zinc finger region:TAZ-type 1, 850118932$zinc finger region:TAZ-type 2, 850118951$zinc finger region:ZZ-type]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),BBID[10000076$56.Macrophage_regulation_of_CD4+T_cells]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),INTERPRO[450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011788$IPR013151:Immunoglobulin, 450012396$IPR013783:Immunoglobulin-like fold]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),KEGG_PATHWAY[470038868$hsa04650:Natural killer cell mediated cytotoxicity, 470038872$hsa04666:Fc gamma R-mediated phagocytosis, 470038916$hsa05322:Systemic lupus erythematosus]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),OMIM_DISEASE[520002972$Lupus erythematosus, systemic, susceptibility, 520003622$Neutropenia, alloimmune neonatal, 520005034$Viral infections, recurrent]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),PIR_SUPERFAMILY[630002118$PIRSF001980:Fc gamma receptor III]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),SMART[760000357$SM00409:IG]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000761$igg-binding protein, 790000768$Immunoglobulin domain, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001555$transmembrane, 790001556$transmembrane protein]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),UP_SEQ_FEATURE[850029060$chain:Low affinity immunoglobulin gamma Fc region receptor III-A, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
G protein-coupled receptor 172B,INTERPRO[450008466$IPR009357:Protein of unknown function DUF1011]
G protein-coupled receptor 172B,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001405$signal, 790001555$transmembrane]
G protein-coupled receptor 172B,UP_SEQ_FEATURE[850039982$chain:Porcine endogenous retrovirus A receptor 2, 850102572$compositionally biased region:Poly-Glu, 850117295$sequence variant, 850117814$signal peptide, 850118623$transmembrane region]
H2B histone family, member M,INTERPRO[450000478$IPR000558:Histone H2B, 450006498$IPR007125:Histone core, 450008207$IPR009072:Histone-fold]
H2B histone family, member M,KEGG_PATHWAY[470038916$hsa05322:Systemic lupus erythematosus]
H2B histone family, member M,SMART[760000373$SM00427:H2B]
H2B histone family, member M,SP_PIR_KEYWORDS[790000315$chromosomal protein, 790000356$complete proteome, 790000466$dna-binding, 790001058$nucleosome core, 790001065$nucleus, 790001212$polymorphism]
H2B histone family, member M,UP_SEQ_FEATURE[850024038$chain:Histone H2B type F-M, 850117295$sequence variant]
KIAA1688 protein,COG_ONTOLOGY[90000102$RNA processing and modification]
KIAA1688 protein,INTERPRO[450000169$IPR000198:RhoGAP, 450000748$IPR000857:Unconventional myosin/plant kinesin-like protein/non-motor protein conserved region MyTH4, 450001055$IPR001202:WW/Rsp5/WWP]
KIAA1688 protein,SMART[760000121$SM00139:MyTH4, 760000293$SM00324:RhoGAP, 760000401$SM00456:WW]
KIAA1688 protein,SP_PIR_KEYWORDS[790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat]
KIAA1688 protein,UP_SEQ_FEATURE[850075563$chain:Uncharacterized protein KIAA1688, 850102586$compositionally biased region:Pro-rich, 850104813$domain:MyTH4, 850105183$domain:Rho-GAP, 850105732$domain:WW 1, 850105733$domain:WW 2, 850106258$modified residue]
LIM homeobox 2,INTERPRO[450001200$IPR001356:Homeobox, 450001575$IPR001781:Zinc finger, LIM-type, 450010997$IPR012287:Homeodomain-related, 450016278$IPR017970:Homeobox, conserved site]
LIM homeobox 2,SMART[760000114$SM00132:LIM, 760000341$SM00389:HOX]
LIM homeobox 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000699$Homeobox, 790000864$LIM domain, 790000937$metal-binding, 790001065$nucleus, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc]
LIM homeobox 2,UP_SEQ_FEATURE[850028672$chain:LIM/homeobox protein Lhx2, 850102565$compositionally biased region:Poly-Ala, 850102927$DNA-binding region:Homeobox, 850104717$domain:LIM zinc-binding 1, 850104718$domain:LIM zinc-binding 2, 850117294$sequence conflict, 850117610$short sequence motif:Nuclear localization signal]
NAD kinase,INTERPRO[450002223$IPR002504:ATP-NAD/AcoX kinase, 450015765$IPR017437:ATP-NAD kinase, PpnK-type, all-beta, 450015766$IPR017438:ATP-NAD kinase, PpnK-type, alpha/beta]
NAD kinase,KEGG_PATHWAY[470038796$hsa00760:Nicotinate and nicotinamide metabolism]
NAD kinase,PIR_SUPERFAMILY[630004861$PIRSF004914:ATP-NAD(H) kinase, 630030337$PIRSF500062:ATP-NAD(H) kinase, eukaryotic type]
NAD kinase,SP_PIR_KEYWORDS[790000138$atp-binding, 790000356$complete proteome, 790000825$kinase, 790000937$metal-binding, 790001006$nad, 790001008$nadp, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001547$transferase]
NAD kinase,UP_SEQ_FEATURE[850033402$chain:NAD kinase, 850102565$compositionally biased region:Poly-Ala, 850102572$compositionally biased region:Poly-Glu, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6, 14kDa,INTERPRO[450007348$IPR008011:Complex 1 LYR protein, 450014809$IPR016488:NADH dehydrogenase [ubiquinone] (complex I), alpha subcomplex, subunit 6]
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6, 14kDa,KEGG_PATHWAY[470038741$hsa00190:Oxidative phosphorylation, 470038891$hsa05010:Alzheimer's disease, 470038892$hsa05012:Parkinson's disease, 470038894$hsa05016:Huntington's disease]
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6, 14kDa,PIR_SUPERFAMILY[630006604$PIRSF006643:NADH dehydrogenase [ubiquinone] (complex I), alpha subcomplex, subunit 6, 630006605$PIRSF006643:NDUA6]
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6, 14kDa,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000489$electron transport, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001006$nad, 790001092$oxidoreductase, 790001212$polymorphism, 790001309$respiratory chain, 790001558$transport]
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6, 14kDa,UP_SEQ_FEATURE[850033526$chain:NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
NK6 homeobox 1,INTERPRO[450000039$IPR000047:Helix-turn-helix motif, lambda-like repressor, 450001200$IPR001356:Homeobox, 450010997$IPR012287:Homeodomain-related, 450016278$IPR017970:Homeobox, conserved site]
NK6 homeobox 1,KEGG_PATHWAY[470038889$hsa04950:Maturity onset diabetes of the young]
NK6 homeobox 1,SMART[760000341$SM00389:HOX]
NK6 homeobox 1,SP_PIR_KEYWORDS[790000020$activator, 790000356$complete proteome, 790000428$developmental protein, 790000466$dna-binding, 790000699$Homeobox, 790001065$nucleus, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
NK6 homeobox 1,UP_SEQ_FEATURE[850024631$chain:Homeobox protein Nkx-6.1, 850102565$compositionally biased region:Poly-Ala, 850102573$compositionally biased region:Poly-Gly, 850102580$compositionally biased region:Poly-Pro, 850102581$compositionally biased region:Poly-Ser, 850102927$DNA-binding region:Homeobox, 850113166$region of interest:Involved in DNA-binding, 850114223$region of interest:Repressor domain, 850117294$sequence conflict]
RAB12, member RAS oncogene family,INTERPRO[450001599$IPR001806:Ras GTPase, 450003146$IPR003579:Ras small GTPase, Rab type, 450004692$IPR005225:Small GTP-binding protein, 450012373$IPR013753:Ras]
RAB12, member RAS oncogene family,SMART[760000149$SM00175:RAB]
RAB12, member RAS oncogene family,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000624$golgi apparatus, 790000639$gtp-binding, 790000881$lipoprotein, 790000919$membrane, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001236$prenylation, 790001266$protein transport, 790001558$transport]
RAB12, member RAS oncogene family,UP_SEQ_FEATURE[850054006$chain:Putative Ras-related protein Rab-12, 850105852$helix, 850105894$lipid moiety-binding region:S-geranylgeranyl cysteine, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP, 850117441$short sequence motif:Effector region, 850118575$strand, 850118624$turn]
SRY (sex determining region Y)-box 10,INTERPRO[450000793$IPR000910:High mobility group, HMG1/HMG2]
SRY (sex determining region Y)-box 10,OMIM_DISEASE[520003945$PCWH, 520005060$Waardenburg syndrome, type IIE, 520005064$Waardenburg-Shah syndrome, 520005134$Yemenite deaf-blind hypopigmentation syndrome]
SRY (sex determining region Y)-box 10,SMART[760000349$SM00398:HMG]
SRY (sex determining region Y)-box 10,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000415$deafness, 790000446$disease mutation, 790000466$dna-binding, 790000693$hirschsprung disease, 790001065$nucleus, 790001162$phosphoprotein, 790001539$Transcription, 790001543$transcription regulation, 790001636$Waardenburg syndrome]
SRY (sex determining region Y)-box 10,UP_SEQ_FEATURE[850065304$chain:Transcription factor SOX-10, 850102573$compositionally biased region:Poly-Gly, 850102920$DNA-binding region:HMG box, 850106258$modified residue, 850117295$sequence variant, 850117605$short sequence motif:Nuclear export signal]
WD repeat domain 82,INTERPRO[450001490$IPR001680:WD40 repeat, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
WD repeat domain 82,SMART[760000289$SM00320:WD40]
WD repeat domain 82,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001638$wd repeat]
WD repeat domain 82,UP_SEQ_FEATURE[850100782$chain:WD repeat-containing protein 82, 850106258$modified residue, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6]
abhydrolase domain containing 14B,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790001065$nucleus]
abhydrolase domain containing 14B,UP_SEQ_FEATURE[850000011$active site:Charge relay system, 850003156$chain:Abhydrolase domain-containing protein 14B, 850105852$helix, 850106258$modified residue, 850118574$splice variant, 850118575$strand]
activating transcription factor 5,INTERPRO[450004309$IPR004827:Basic-leucine zipper (bZIP) transcription factor, 450010446$IPR011616:bZIP transcription factor, bZIP-1]
activating transcription factor 5,PIR_SUPERFAMILY[630016200$PIRSF019614:cyclic AMP-dependent transcription factor, ATF4 type]
activating transcription factor 5,SMART[760000306$SM00338:BRLZ]
activating transcription factor 5,SP_PIR_KEYWORDS[790000020$activator, 790000356$complete proteome, 790000407$cytoplasm, 790000466$dna-binding, 790001065$nucleus, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
activating transcription factor 5,UP_SEQ_FEATURE[850012982$chain:Cyclic AMP-dependent transcription factor ATF-5, 850102580$compositionally biased region:Poly-Pro, 850102900$DNA-binding region:Basic motif, 850104712$domain:Leucine-zipper, 850112729$region of interest:Interaction with PTP4A1, 850117294$sequence conflict, 850117295$sequence variant]
annexin A6,INTERPRO[450001304$IPR001464:Annexin, 450002126$IPR002393:Annexin, type VI, 450016537$IPR018252:Annexin repeat, conserved site, 450016775$IPR018502:Annexin repeat]
annexin A6,PIR_SUPERFAMILY[630002477$PIRSF002359:annexin I, 630002479$PIRSF002361:annexin VI]
annexin A6,SMART[760000303$SM00335:ANX]
annexin A6,SP_PIR_KEYWORDS[790000002$3d-structure, 790000011$acetylated amino end, 790000012$acetylation, 790000088$annexin, 790000211$calcium, 790000212$calcium binding, 790000216$calcium/phospholipid-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000473$duplication, 790000497$endonexin fold, 790001155$phospholipid binding, 790001162$phosphoprotein, 790001304$repeat]
annexin A6,UP_SEQ_FEATURE[850005459$chain:Annexin A6, 850105852$helix, 850106258$modified residue, 850115661$repeat:Annexin 1, 850115662$repeat:Annexin 2, 850115663$repeat:Annexin 3, 850115664$repeat:Annexin 4, 850115665$repeat:Annexin 5, 850115666$repeat:Annexin 6, 850115667$repeat:Annexin 7, 850115668$repeat:Annexin 8, 850117294$sequence conflict, 850118575$strand, 850118624$turn]
canopy 3 homolog (zebrafish),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000447$disulfide bond, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000763$immune response, 790000777$innate immunity, 790001212$polymorphism, 790001405$signal]
canopy 3 homolog (zebrafish),UP_SEQ_FEATURE[850045312$chain:Protein canopy homolog 3, 850102883$disulfide bond, 850105263$domain:Saposin B-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
chromosome 7 open reading frame 44,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
chromosome 7 open reading frame 44,UP_SEQ_FEATURE[850074424$chain:Uncharacterized protein C7orf44, 850117294$sequence conflict, 850118623$transmembrane region]
collagen, type XV, alpha 1,INTERPRO[450001584$IPR001791:Laminin G, 450002753$IPR003129:Laminin G, thrombospondin-type, N-terminal, 450007490$IPR008160:Collagen triple helix repeat, 450009569$IPR010515:Collagenase NC10 and endostatin, 450011359$IPR012680:Laminin G, subdomain 2, 450014523$IPR016186:C-type lectin-like]
collagen, type XV, alpha 1,SMART[760000183$SM00210:TSPN, 760000253$SM00282:LamG]
collagen, type XV, alpha 1,SP_PIR_KEYWORDS[790000081$angiogenesis, 790000256$cell adhesion, 790000345$collagen, 790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790000447$disulfide bond, 790000530$extracellular matrix, 790000616$glycoprotein, 790000745$hydroxylation, 790001212$polymorphism, 790001304$repeat, 790001363$Secreted, 790001405$signal]
collagen, type XV, alpha 1,UP_SEQ_FEATURE[850012190$chain:Collagen alpha-1(XV) chain, 850017421$chain:Endostatin, 850105553$domain:TSP N-terminal, 850105770$glycosylation site:N-linked (GlcNAc...), 850110431$region of interest:4 X tandem repeats, 850113771$region of interest:Nonhelical region 1 (NC1), 850113772$region of interest:Nonhelical region 10 (NC10), 850113774$region of interest:Nonhelical region 2 (NC2), 850113775$region of interest:Nonhelical region 3 (NC3), 850113776$region of interest:Nonhelical region 4 (NC4), 850113777$region of interest:Nonhelical region 5 (NC5), 850113778$region of interest:Nonhelical region 6 (NC6), 850113779$region of interest:Nonhelical region 7 (NC7), 850113780$region of interest:Nonhelical region 8 (NC8), 850113781$region of interest:Nonhelical region 9 (NC9), 850114944$region of interest:Triple-helical region 1 (COL1), 850114949$region of interest:Triple-helical region 2 (COL2), 850114951$region of interest:Triple-helical region 3 (COL3), 850114952$region of interest:Triple-helical region 4 (COL4), 850114954$region of interest:Triple-helical region 5 (COL5), 850114956$region of interest:Triple-helical region 6 (COL6), 850114958$region of interest:Triple-helical region 7 (COL7), 850114960$region of interest:Triple-helical region 8 (COL8), 850114962$region of interest:Triple-helical region 9 (COL9), 850115074$repeat:1, 850115273$repeat:2, 850115417$repeat:3, 850115467$repeat:4, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide]
dachsous 2 (Drosophila),INTERPRO[450001884$IPR002126:Cadherin]
dachsous 2 (Drosophila),SMART[760000099$SM00112:CA]
dachsous 2 (Drosophila),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000256$cell adhesion, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane]
dachsous 2 (Drosophila),UP_SEQ_FEATURE[850048758$chain:Protocadherin-23, 850103211$domain:Cadherin 1, 850103212$domain:Cadherin 10, 850103213$domain:Cadherin 11, 850103214$domain:Cadherin 12, 850103215$domain:Cadherin 13, 850103216$domain:Cadherin 14, 850103217$domain:Cadherin 15, 850103218$domain:Cadherin 16, 850103219$domain:Cadherin 17, 850103220$domain:Cadherin 18, 850103221$domain:Cadherin 19, 850103222$domain:Cadherin 2, 850103223$domain:Cadherin 20, 850103224$domain:Cadherin 21, 850103225$domain:Cadherin 22, 850103233$domain:Cadherin 3, 850103239$domain:Cadherin 4, 850103240$domain:Cadherin 5, 850103241$domain:Cadherin 6, 850103242$domain:Cadherin 7, 850103243$domain:Cadherin 8, 850103244$domain:Cadherin 9, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
deoxyribonuclease I-like 1,INTERPRO[450004603$IPR005135:Endonuclease/exonuclease/phosphatase, 450007506$IPR008185:Deoxyribonuclease I, eukaryotic, 450014526$IPR016202:Deoxyribonuclease I-like, 450016360$IPR018057:Deoxyribonuclease I, active site]
deoxyribonuclease I-like 1,PIR_SUPERFAMILY[630001140$PIRSF000988:deoxyribonuclease I, 630001141$PIRSF000988:DNase_I_euk]
deoxyribonuclease I-like 1,SMART[760000421$SM00476:DNaseIc]
deoxyribonuclease I-like 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000447$disulfide bond, 790000498$Endonuclease, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000743$hydrolase, 790001049$nuclease, 790001212$polymorphism, 790001405$signal]
deoxyribonuclease I-like 1,UP_SEQ_FEATURE[850014875$chain:Deoxyribonuclease-1-like 1, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide]
dephospho-CoA kinase domain containing,COG_ONTOLOGY[90000046$Coenzyme metabolism]
dephospho-CoA kinase domain containing,INTERPRO[450001751$IPR001977:Dephospho-CoA kinase]
dephospho-CoA kinase domain containing,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790001063$nucleotide-binding, 790001212$polymorphism]
dephospho-CoA kinase domain containing,UP_SEQ_FEATURE[850014897$chain:Dephospho-CoA kinase domain-containing protein, 850103544$domain:DPCK, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
exosome component 7,COG_ONTOLOGY[90000125$Translation, ribosomal structure and biogenesis]
exosome component 7,INTERPRO[450001098$IPR001247:Exoribonuclease, phosphorolytic domain 1, 450014270$IPR015847:Exoribonuclease, phosphorolytic domain 2]
exosome component 7,KEGG_PATHWAY[470038814$hsa03018:RNA degradation]
exosome component 7,PIR_SUPERFAMILY[630006618$PIRSF006657:exosome complex 3'-5' exonuclease]
exosome component 7,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000523$exonuclease, 790000526$exosome, 790000743$hydrolase, 790001049$nuclease, 790001065$nucleus, 790001212$polymorphism, 790001339$rna-binding, 790001345$rrna processing]
exosome component 7,UP_SEQ_FEATURE[850018277$chain:Exosome complex exonuclease RRP42, 850105852$helix, 850106258$modified residue, 850117295$sequence variant, 850118575$strand, 850118624$turn]
family with sequence similarity 101, member A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
family with sequence similarity 101, member A,UP_SEQ_FEATURE[850045811$chain:Protein FAM101A, 850117294$sequence conflict, 850118574$splice variant]
follistatin-like 3 (secreted glycoprotein),INTERPRO[450002091$IPR002350:Proteinase inhibitor I1, Kazal, 450003191$IPR003645:Follistatin-like, N-terminal, 450010359$IPR011497:Protease inhibitor, Kazal-type, 450011589$IPR012913:Glucosidase II beta subunit-like, 450013810$IPR015369:Follistatin/Osteonectin-like EGF domain, 450016196$IPR017878:TGF-beta binding]
follistatin-like 3 (secreted glycoprotein),SMART[760000246$SM00274:FOLN, 760000251$SM00280:KAZAL]
follistatin-like 3 (secreted glycoprotein),SP_PIR_KEYWORDS[790000002$3d-structure, 790000050$alternative initiation, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790001065$nucleus, 790001083$osteogenesis, 790001271$Proto-oncogene, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001539$Transcription, 790001543$transcription regulation]
follistatin-like 3 (secreted glycoprotein),UP_SEQ_FEATURE[850019807$chain:Follistatin-related protein 3, 850102883$disulfide bond, 850104011$domain:Follistatin-like 2, 850104501$domain:Kazal-like 1, 850104509$domain:Kazal-like 2, 850105464$domain:TB, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106259$mutagenesis site, 850117814$signal peptide, 850118574$splice variant, 850118575$strand]
forkhead box E1 (thyroid transcription factor 2),INTERPRO[450001565$IPR001766:Transcription factor, fork head, 450010816$IPR011991:Winged helix repressor DNA-binding, 450016421$IPR018122:Transcription factor, fork head, conserved site]
forkhead box E1 (thyroid transcription factor 2),OMIM_DISEASE[520000504$Bamforth-Lazarus syndrome]
forkhead box E1 (thyroid transcription factor 2),SMART[760000307$SM00339:FH]
forkhead box E1 (thyroid transcription factor 2),SP_PIR_KEYWORDS[790000356$complete proteome, 790000446$disease mutation, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
forkhead box E1 (thyroid transcription factor 2),UP_SEQ_FEATURE[850019855$chain:Forkhead box protein E1, 850102378$compositionally biased region:Ala-rich, 850102565$compositionally biased region:Poly-Ala, 850102586$compositionally biased region:Pro-rich, 850102914$DNA-binding region:Fork-head, 850117295$sequence variant]
fucosyltransferase 1 (galactoside 2-alpha-L-fucosyltransferase, H blood group),INTERPRO[450002236$IPR002516:Glycosyl transferase, family 11]
fucosyltransferase 1 (galactoside 2-alpha-L-fucosyltransferase, H blood group),KEGG_PATHWAY[470038784$hsa00601:Glycosphingolipid biosynthesis, 470038785$hsa00603:Glycosphingolipid biosynthesis]
fucosyltransferase 1 (galactoside 2-alpha-L-fucosyltransferase, H blood group),OMIM_DISEASE[520000641$Bombay phenotype]
fucosyltransferase 1 (galactoside 2-alpha-L-fucosyltransferase, H blood group),SP_PIR_KEYWORDS[790000194$blood group antigen, 790000356$complete proteome, 790000616$glycoprotein, 790000619$glycosyltransferase, 790000624$golgi apparatus, 790000691$hexosyltransferase, 790000919$membrane, 790001212$polymorphism, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane, 790001556$transmembrane protein]
fucosyltransferase 1 (galactoside 2-alpha-L-fucosyltransferase, H blood group),UP_SEQ_FEATURE[850020414$chain:Galactoside 2-alpha-L-fucosyltransferase 1, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
inhibitor of growth family, member 4,COG_ONTOLOGY[90000042$Chromatin structure and dynamics]
inhibitor of growth family, member 4,INTERPRO[450001740$IPR001965:Zinc finger, PHD-type, 450018019$IPR019786:Zinc finger, PHD-type, conserved site, 450018020$IPR019787:Zinc finger, PHD-finger]
inhibitor of growth family, member 4,PIR_SUPERFAMILY[630014443$PIRSF017781:uncharacterized conserved protein]
inhibitor of growth family, member 4,SMART[760000221$SM00249:PHD]
inhibitor of growth family, member 4,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000258$cell cycle, 790000311$chromatin regulator, 790000344$coiled coil, 790000356$complete proteome, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001580$tumor suppressor, 790001648$zinc, 790001651$zinc-finger]
inhibitor of growth family, member 4,UP_SEQ_FEATURE[850025778$chain:Inhibitor of growth protein 4, 850105852$helix, 850106258$modified residue, 850118574$splice variant, 850118575$strand, 850118624$turn, 850118877$zinc finger region:PHD-type]
kaptin (actin binding protein),SP_PIR_KEYWORDS[790000019$actin-binding, 790000267$cell projection, 790000356$complete proteome, 790000407$cytoplasm]
kaptin (actin binding protein),UP_SEQ_FEATURE[850027055$chain:Kaptin, 850117294$sequence conflict]
multiple EGF-like-domains 6,INTERPRO[450000128$IPR000152:EGF-type aspartate/asparagine hydroxylation conserved site, 450000637$IPR000742:EGF-like, type 3, 450001663$IPR001881:EGF-like calcium-binding, 450001815$IPR002049:EGF-like, laminin, 450005635$IPR006209:EGF, 450005636$IPR006210:EGF-like, 450011699$IPR013032:EGF-like region, conserved site, 450011735$IPR013091:EGF calcium-binding, 450011755$IPR013111:EGF, extracellular, 450016397$IPR018097:EGF-like calcium-binding, conserved site]
multiple EGF-like-domains 6,SMART[760000153$SM00179:EGF_CA, 760000154$SM00180:EGF_Lam, 760000155$SM00181:EGF]
multiple EGF-like-domains 6,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000356$complete proteome, 790000447$disulfide bond, 790000481$egf-like domain, 790000616$glycoprotein, 790001212$polymorphism, 790001304$repeat, 790001363$Secreted, 790001405$signal]
multiple EGF-like-domains 6,UP_SEQ_FEATURE[850032780$chain:Multiple epidermal growth factor-like domains protein 6, 850102883$disulfide bond, 850103597$domain:EGF-like 1, 850103598$domain:EGF-like 10, 850103601$domain:EGF-like 11, 850103603$domain:EGF-like 12, 850103605$domain:EGF-like 13, 850103607$domain:EGF-like 14, 850103609$domain:EGF-like 15, 850103611$domain:EGF-like 16, 850103613$domain:EGF-like 17, 850103615$domain:EGF-like 18, 850103617$domain:EGF-like 19, 850103624$domain:EGF-like 20, 850103626$domain:EGF-like 21, 850103628$domain:EGF-like 22, 850103630$domain:EGF-like 23, 850103632$domain:EGF-like 24, 850103634$domain:EGF-like 25, 850103636$domain:EGF-like 26, 850103638$domain:EGF-like 27, 850103644$domain:EGF-like 2; calcium-binding, 850103646$domain:EGF-like 3, 850103668$domain:EGF-like 4, 850103693$domain:EGF-like 5; calcium-binding, 850103695$domain:EGF-like 6, 850103698$domain:EGF-like 7, 850103701$domain:EGF-like 8; calcium-binding, 850103702$domain:EGF-like 9, 850103714$domain:EMI, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
non-SMC condensin I complex, subunit D2,BIOCARTA[30000012$h_akap95Pathway:AKAP95 role in mitosis and chromosome dynamics]
non-SMC condensin I complex, subunit D2,COG_ONTOLOGY[90000043$Chromatin structure and dynamics / Cell division and chromosome partitioning]
non-SMC condensin I complex, subunit D2,INTERPRO[450007030$IPR007673:Non-SMC condensin subunit, XCAP-D2/Cnd1]
non-SMC condensin I complex, subunit D2,PIR_SUPERFAMILY[630013895$PIRSF017127:chromosome condensation complex condensin, subunit D2, 630013896$PIRSF017127:Condensin_D2]
non-SMC condensin I complex, subunit D2,SP_PIR_KEYWORDS[790000258$cell cycle, 790000260$cell division, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000451$dna condensation, 790000973$mitosis, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
non-SMC condensin I complex, subunit D2,UP_SEQ_FEATURE[850012418$chain:Condensin complex subunit 1, 850106258$modified residue, 850106259$mutagenesis site, 850113078$region of interest:Interactions with SMC2 and SMC4, 850117294$sequence conflict, 850117295$sequence variant, 850117325$short sequence motif:Bipartite nuclear localization signal]
phytanoyl-CoA 2-hydroxylase,INTERPRO[450008026$IPR008775:Phytanoyl-CoA dioxygenase]
phytanoyl-CoA 2-hydroxylase,OMIM_DISEASE[520004218$Refsum disease]
phytanoyl-CoA 2-hydroxylase,PIR_SUPERFAMILY[630013151$PIRSF016380:Caenorhabditis elegans hypothetical protein ZK550.6]
phytanoyl-CoA 2-hydroxylase,SP_PIR_KEYWORDS[790000002$3d-structure, 790000252$cataract, 790000356$complete proteome, 790000415$deafness, 790000437$dioxygenase, 790000446$disease mutation, 790000757$Ichthyosis, 790000802$iron, 790000937$metal-binding, 790001092$oxidoreductase, 790001128$peroxisome, 790001130$peroxisome biogenesis disorder, 790001212$polymorphism, 790001316$retinitis pigmentosa, 790001377$sensory transduction, 790001550$transit peptide, 790001622$vision, 790001626$vitamin c]
phytanoyl-CoA 2-hydroxylase,UP_SEQ_FEATURE[850000225$binding site:Alpha-ketoglutarate, 850039107$chain:Phytanoyl-CoA dioxygenase, peroxisomal, 850105852$helix, 850106003$metal ion-binding site:Iron, 850110916$region of interest:Alpha-ketoglutarate binding, 850117295$sequence variant, 850118575$strand, 850118621$transit peptide:Peroxisome]
pleckstrin homology domain containing, family G (with RhoGef domain) member 2,INTERPRO[450000189$IPR000219:Dbl homology (DH) domain, 450001173$IPR001331:Guanine-nucleotide dissociation stimulator, CDC24, conserved site, 450001635$IPR001849:Pleckstrin homology, 450010818$IPR011993:Pleckstrin homology-type]
pleckstrin homology domain containing, family G (with RhoGef domain) member 2,SMART[760000205$SM00233:PH, 760000294$SM00325:RhoGEF]
pleckstrin homology domain containing, family G (with RhoGef domain) member 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000641$guanine-nucleotide releasing factor, 790001162$phosphoprotein, 790001212$polymorphism, 790001580$tumor suppressor]
pleckstrin homology domain containing, family G (with RhoGef domain) member 2,UP_SEQ_FEATURE[850039561$chain:Pleckstrin homology domain-containing family G member 2, 850102572$compositionally biased region:Poly-Glu, 850102573$compositionally biased region:Poly-Gly, 850102580$compositionally biased region:Poly-Pro, 850102586$compositionally biased region:Pro-rich, 850103518$domain:DH, 850104979$domain:PH, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
poly(rC) binding protein 1,INTERPRO[450003603$IPR004088:K Homology, type 1, 450016411$IPR018111:K Homology, type 1, subgroup]
poly(rC) binding protein 1,KEGG_PATHWAY[470038818$hsa03040:Spliceosome]
poly(rC) binding protein 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001325$ribonucleoprotein, 790001339$rna-binding]
poly(rC) binding protein 1,UP_SEQ_FEATURE[850039768$chain:Poly(rC)-binding protein 1, 850104521$domain:KH 1, 850104527$domain:KH 2, 850104528$domain:KH 3, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850118575$strand]
ribosomal RNA processing 8, methyltransferase, homolog (yeast),SP_PIR_KEYWORDS[790000002$3d-structure, 790000311$chromatin regulator, 790000356$complete proteome, 790000954$methyltransferase, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001307$repressor, 790001345$rrna processing, 790001348$s-adenosyl-l-methionine, 790001539$Transcription, 790001543$transcription regulation, 790001547$transferase]
ribosomal RNA processing 8, methyltransferase, homolog (yeast),UP_SEQ_FEATURE[850000532$binding site:S-adenosyl-L-methionine, 850000543$binding site:S-adenosyl-L-methionine; via carbonyl oxygen, 850057963$chain:Ribosomal RNA-processing protein 8, 850102572$compositionally biased region:Poly-Glu, 850105852$helix, 850106258$modified residue, 850117295$sequence variant, 850118575$strand, 850118624$turn]
ring finger protein 139,COG_ONTOLOGY[90000095$Posttranslational modification, protein turnover, chaperones]
ring finger protein 139,INTERPRO[450001628$IPR001841:Zinc finger, RING-type, 450016222$IPR017907:Zinc finger, RING-type, conserved site, 450017227$IPR018957:Zinc finger, C3HC4 RING-type]
ring finger protein 139,OMIM_DISEASE[520004226$Renal cell carcinoma]
ring finger protein 139,SMART[760000158$SM00184:RING]
ring finger protein 139,SP_PIR_KEYWORDS[790000316$chromosomal rearrangement, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000859$ligase, 790000919$membrane, 790000937$metal-binding, 790001162$phosphoprotein, 790001301$receptor, 790001555$transmembrane, 790001593$ubl conjugation pathway, 790001648$zinc, 790001651$zinc-finger]
ring finger protein 139,UP_SEQ_FEATURE[850058184$chain:RING finger protein 139, 850106258$modified residue, 850117294$sequence conflict, 850118623$transmembrane region, 850118919$zinc finger region:RING-type; atypical]
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B,INTERPRO[450001441$IPR001627:Semaphorin/CD100 antigen, 450001920$IPR002165:Plexin, 450003160$IPR003599:Immunoglobulin subtype, 450003205$IPR003659:Plexin/semaphorin/integrin, 450006486$IPR007110:Immunoglobulin-like, 450011750$IPR013106:Immunoglobulin V-set, 450012396$IPR013783:Immunoglobulin-like fold, 450014355$IPR015943:WD40/YVTN repeat-like]
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B,KEGG_PATHWAY[470038851$hsa04360:Axon guidance]
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B,PIR_SUPERFAMILY[630005453$PIRSF005526:semaphorin]
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B,SMART[760000357$SM00409:IG, 760000369$SM00423:PSI, 760000545$SM00630:Sema]
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000446$disease mutation, 790000447$disulfide bond, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790001363$Secreted, 790001405$signal]
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B,UP_SEQ_FEATURE[850059293$chain:Semaphorin-3B, 850102405$compositionally biased region:Arg-rich (basic), 850102573$compositionally biased region:Poly-Gly, 850102883$disulfide bond, 850104355$domain:Ig-like C2-type, 850105337$domain:Sema, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
zinc finger protein 16,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger protein 16,INTERPRO[450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 16,SMART[760000323$SM00355:ZnF_C2H2]
zinc finger protein 16,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000449$DNA binding, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001649$zinc finger, 790001651$zinc-finger]
zinc finger protein 16,UP_SEQ_FEATURE[850101462$chain:Zinc finger protein 16, 850106258$modified residue, 850117295$sequence variant, 850118657$zinc finger region:C2H2-type 10, 850118660$zinc finger region:C2H2-type 11, 850118663$zinc finger region:C2H2-type 12, 850118666$zinc finger region:C2H2-type 13, 850118669$zinc finger region:C2H2-type 14, 850118671$zinc finger region:C2H2-type 15, 850118674$zinc finger region:C2H2-type 16, 850118676$zinc finger region:C2H2-type 17, 850118686$zinc finger region:C2H2-type 1; degenerate, 850118709$zinc finger region:C2H2-type 2; degenerate, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118731$zinc finger region:C2H2-type 7, 850118734$zinc finger region:C2H2-type 8, 850118737$zinc finger region:C2H2-type 9]
zinc finger protein 793,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger protein 793,INTERPRO[450001691$IPR001909:Krueppel-associated  box, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 793,SMART[760000317$SM00349:KRAB, 760000323$SM00355:ZnF_C2H2]
zinc finger protein 793,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 793,UP_SEQ_FEATURE[850101925$chain:Zinc finger protein 793, 850104552$domain:KRAB, 850117295$sequence variant, 850118574$splice variant, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5]
